End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
55.8 TWD | -0.36% | +0.36% | -8.67% |
Mar. 14 | CHC Healthcare Group Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 13 | CHC Healthcare Group Proposes Dividend Distribution for the Year Ended December 31, 2023 | CI |
Sales 2024 * | 4.34B 133M | Sales 2025 * | - | Capitalization | 9.36B 287M |
---|---|---|---|---|---|
Net income 2024 * | 566M 17.38M | Net income 2025 * | 717M 22.01M | EV / Sales 2024 * | 2.16 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
16.4
x | P/E ratio 2025 * |
12.9
x | Employees | - |
Yield 2024 * |
4.87% | Yield 2025 * |
-
| Free-Float | 59.81% |
1 day | -0.36% | ||
1 week | +0.36% | ||
Current month | -7.46% | ||
1 month | -7.77% | ||
3 months | -1.76% | ||
6 months | -11.57% | ||
Current year | -8.67% |
Managers | Title | Age | Since |
---|---|---|---|
Pei Lin Lee
CEO | Chief Executive Officer | - | 09-11-24 |
Yi Chun Chen
DFI | Director of Finance/CFO | - | 11-01-31 |
Ming Lun Lee
COO | Chief Operating Officer | - | 10-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Yung Shun Chuang
BRD | Director/Board Member | - | 14-06-16 |
Pei Lin Lee
CEO | Chief Executive Officer | - | 09-11-24 |
Kuei Tuan Chen
BRD | Director/Board Member | - | 12-01-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 55.8 | -0.36% | 372,074 |
24-04-25 | 56 | -0.71% | 272,757 |
24-04-24 | 56.4 | 0.00% | 387,758 |
24-04-23 | 56.4 | 0.00% | 272,946 |
24-04-22 | 56.4 | +1.44% | 460,449 |
End-of-day quote Taiwan S.E., April 25, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.67% | 287M | |
+13.93% | 198M | |
+26.13% | 77.74M | |
+20.48% | 65.76M |
- Stock Market
- Equities
- 4164 Stock